enow.com Web Search

  1. Ad

    related to: how is benlysta administered in hospital for coronavirus treatment

Search results

  1. Results from the WOW.Com Content Network
  2. Belimumab - Wikipedia

    en.wikipedia.org/wiki/Belimumab

    Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), [6] also known as B-lymphocyte stimulator (BLyS). [7] It is approved in the United States [ 8 ] and Canada, [ 9 ] and the European Union [ 5 ] to treat systemic lupus erythematosus and lupus nephritis.

  3. Treatment and management of COVID-19 - Wikipedia

    en.wikipedia.org/wiki/Treatment_and_management...

    This registry based, multi-center, multi-country data provide provisional support for the use of ECMO for COVID-19 associated acute hypoxemic respiratory failure. Given that this is a complex technology that can be resource intense, guidelines exist for the use of ECMO during the COVID-19 pandemic. [85] [86] [87]

  4. COVID-19 hospital - Wikipedia

    en.wikipedia.org/wiki/COVID-19_Hospital

    A similar set-up of temporary COVID-19 hospital has been widely adapted worldwide to offer treatment and disease monitoring to patients with mild symptoms. COVID-19 hospital is a general name given to clinical institutions that provide medical treatment to Coronavirus Disease 2019 (COVID-19) infected patients. [1]

  5. No Sign that Plasma from Recovered Patients Is an Effective ...

    www.aol.com/news/no-sign-plasma-recovered...

    The National Institutes of Health said that there is no compelling evidence that plasma works against COVID-19, just days after President Trump called it a “breakthrough” treatment

  6. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    Therapeutic, diagnostic and preventive monoclonal antibodies are clones of a single parent cell. When used as drugs, the International Nonproprietary Names (INNs) end in -mab.

  7. COVID-19 drug development - Wikipedia

    en.wikipedia.org/wiki/COVID-19_drug_development

    Bamlanivimab and etesevimab, administered together, are authorized in the United States for the treatment of mild-to-moderate COVID-19 in people aged twelve years of age and older weighing at least 40 kilograms (88 lb) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19 ...

  8. RECOVERY Trial - Wikipedia

    en.wikipedia.org/wiki/Recovery_trial

    The Randomised Evaluation of COVID-19 Therapy (RECOVERY Trial) [1] is a large-enrollment clinical trial of possible treatments for people in the United Kingdom admitted to hospital with severe COVID-19 infection. [2] [3] [4] The trial was later expanded to Indonesia, Nepal and Vietnam. [5]

  9. COVID-19 drug repurposing research - Wikipedia

    en.wikipedia.org/wiki/COVID-19_drug_repurposing...

    In July 2020, the European Medicines Agency (EMA) started reviewing results from the RECOVERY study arm that involved the use of dexamethasone in the treatment of patients with COVID-19 admitted to the hospital to provide an opinion on the results. It focused particularly on the potential use of the drug for the treatment of adults with COVID-19.

  1. Ad

    related to: how is benlysta administered in hospital for coronavirus treatment